Form 8-K · Current report
Axon Enterprise 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0001069183
- Accession no.
- 0001628280-26-053363
Summary
Axon Enterprise reported Q2 2026 revenue of $904 million, up 35% year over year, and raised its full-year revenue growth outlook to 32% to 34%.
Key points
- Q2 2026 revenue rose 35% year over year to $904 million, the 10th consecutive quarter of revenue growth above 30%.
- Software & Services revenue grew 36% to $398 million, Connected Devices revenue grew 35% to $507 million, and Platform Solutions revenue grew 123% to $150 million.
- Annual recurring revenue grew 39% to $1.6 billion, net revenue retention reached 126%, and net income was $29 million.
- Full-year 2026 revenue growth outlook was raised to 32%–34% from 30%–32%, while the Adjusted EBITDA margin outlook was maintained at approximately 25.5%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On August 5, 2026, Axon Enterprise, Inc. (the “Company”) issued a shareholder letter regarding the Company’s financial results for the three and six months ended June 30, 2026. The full text of the letter is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information pursuant to Item 2.02 in this report on Form 8-K is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference into any of the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.